Moreover, silymarin also has an anti-inflammatory function, which can suppress the expression of proinflammatory cytokines such as interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α) and is closely associated with the regulation of expression of cytokines IL-2, IL-8, and IL-10, which are responsible for “cytokine storms” in COVID-19 patients [29,30,31,32]. This evidence concerns the gene IL6 and COVID-19.